Skip to main content
. 2020 Nov 23;181(2):282–284. doi: 10.1001/jamainternmed.2020.4799

Table 1. Summary of NNT, NNH, and ARR Reporting in Controlled Clinical Trials From 6 Widely Cited General Medical Journals.

Journal by year All trials (n = 875) Trials with a statistically significant result (n = 624)a Trials without a statistically significant result (n = 251)a
Total No. (%) of trials with at least 1 reported Total No. (%) of trials with at least 1 reported Total No. (%) of trials with at least 1 reported
NNT NNH ARR NNT and/or NNH NNT, NNH, and/or ARR NNT and/or NNH NNT, NNH, and/or ARR NNT and/or NNH NNT, NNH, and/or ARR
2001
NEJM 57 3 (5.3) 0 7 (12.3) 3 (5.3) 9 (15.8) 51 3 (5.9) 9 (17.6) 6 0 0
Lancet 21 2 (9.5) 0 5 (23.8) 2 (9.5) 6 (28.6) 16 2 (12.5) 4 (25.0) 5 0 2 (40.0)
JAMA 27 2 (7.4) 1 (3.7) 2 (7.4) 2 (7.4) 3 (11.1) 20 1 (5.0) 2 (10.0) 7 1 (14.3) 1 (14.3)
BMJ 20 3 (15.0) 0 9 (45.0) 3 (15.0) 10 (50.0) 13 3 (23.1) 9 (69.2) 7 0 1 (14.3)
JAMA IM 10 2 (20.0) 0 2 (20.0) 2 (20.0) 4 (40.0) 7 2 (28.6) 3 (42.9) 3 0 1 (33.3)
Annals IM 5 0 0 1 (20.0) 0 1 (20.0) 5 0 1 (20.0) 0 0 0
Total 140 12 (8.6) 1 (0.7) 26 (18.6) 12 (8.6) 33 (23.6) 112 11 (9.8) 28 (25.0) 28 1 (3.6) 5 (17.9)
2007
NEJM 72 5 (6.9) 0 17 (23.6) 5 (6.9) 18 (25.0) 61 5 (8.2) 16 (26.2) 11 0 2 (18.2)
Lancet 46 4 (8.7) 1 (2.2) 14 (30.4) 4 (8.7) 16 (34.8) 35 4 (11.4) 13 (37.1) 11 0 3 (27.3)
JAMA 31 5 (16.1) 0 5 (16.1) 5 (16.1) 7 (22.6) 15 4 (26.7) 5 (33.3) 16 1 (6.3) 2 (12.5)
BMJ 25 6 (24.0) 0 6 (24.0) 6 (24.0) 8 (32.0) 22 6 (27.3) 7 (31.8) 3 0 1 (33.3)
JAMA IM 20 0 0 4 (20.0) 0 4 (20.0) 19 0 3 (15.8) 1 0 1 (100)
Annals IM 18 1 (5.6) 0 12 (66.7) 1 (5.6) 12 (66.7) 13 1 (7.7) 8 (61.5) 5 0 4 (80.0)
Total 212 21 (9.9) 1 (0.5) 58 (27.4) 21 (9.9) 65 (30.7) 165 20 (12.1) 52 (31.5) 47 1 (2.1) 13 (27.7)
2013
NEJM 85 6 (7.1) 0 15 (17.6) 6 (7.1) 18 (21.2) 62 6 (9.7) 15 (24.2) 23 0 3 (20.0)
Lancet 64 4 (6.3) 1 (1.6) 17 (26.6) 5 (7.8) 22 (34.4) 42 5 (11.9) 16 (38.1) 22 0 6 (37.5)
JAMA 41 5 (12.2) 0 11 (26.8) 5 (12.2) 14 (34.2) 25 5 (20.0) 9 (36.0) 16 0 5 (31.3)
BMJ 20 1 (5.0) 0 4 (20.0) 1 (5.0) 5 (25.0) 11 0 2 (18.2) 9 1 (11.1) 3 (33.3)
JAMA IM 15 4 (26.7) 0 3 (20.0) 4 (26.7) 5 (33.0) 12 3 (25.0) 4 (33.3) 3 1 (33.3) 1 (33.3)
Annals IM 16 0 0 10 (62.5) 0 10 (62.5) 11 0 5 (45.5) 5 0 5 (100)
Total 241 20 (8.3) 1 (0.4) 60 (24.9) 21 (8.7) 74 (30.7) 163 19 (11.7) 51 (31.3) 78 2 (2.6) 23 (29.5)
2019
NEJM 115 9 (7.8) 3 (2.6) 25 (21.7) 10 (8.7) 31 (27.0) 79 10 (12.7) 25 (31.6) 36 0 6 (16.7)
Lancet 86 10 (11.6) 2 (2.3) 32 (37.2) 12 (14.0) 38 (44.2) 60 11 (18.3) 34 (56.7) 26 1 (3.8) 4 (15.4)
JAMA 61 0 0 42 (68.9) 0 42 (68.9) 32 0 23 (71.9) 29 0 19 (65.6)
BMJ 9 2 (22.2) 0 2 (22.2) 2 (22.2) 3 (33.3) 6 2 (33.3) 2 (33.3) 3 0 1 (33.3)
JAMA IM 7 2 (28.6) 0 0 2 (28.6) 2 (28.6) 6 2 (33.3) 2 (33.3) 1 0 0
Annals IM 4 0 0 4 (100) 0 4 (1.0) 1 0 1 (100) 3 0 3 (100)
Total 282 23 (8.2) 5 1.8) 105 (37.2) 26 (9.2) 120 (42.6) 184 25 (13.6) 87 (47.4) 98 1 (1.0) 33 (33.7)
All years 875 76 (8.7) 8 (0.9) 249 (28.5) 80 (9.1) 292 (33.4) 624 75 (12.0) 218 (34.9) 251 5 (2.0) 74 (29.5)

Abbreviations: Annals IM, Annals of Internal Medicine; ARR, absolute risk reduction; BMJ, British Medical Journal; JAMA, Journal of the American Medical Association; JAMA IM, JAMA Internal Medicine (formerly Archives of Internal Medicine); NEJM, New England Journal of Medicine; NNH, number needed to harm; NNT, number needed to treat.

a

At least 1 statistically significant (P < .05) finding for a binary efficacy or safety outcome or a hazard ratio reported in the abstract of a trial.